Each imaging modality has its own unique strengths. Multimodality imaging, taking
advantages of strengths from two or more imaging modalities, can provide overall structural …

Nuclear medicine imaging has been developed as a powerful diagnostic approach for
cancers by detecting gamma rays directly or indirectly from radionuclides to construct …

Targeted nanoparticle imaging agents provide many benefits and new opportunities to
facilitate accurate diagnosis of cancer and significantly impact patient outcome. Due to the …

Accurate diagnosis of tumors needs much detailed information. However, available single
imaging modality cannot provide complete or comprehensive data. Nanomedicine is the …

Advances in nanotechnology have contributed to the development of novel nanoparticles
that enable the tumor‐specific delivery of imaging probes and therapeutic agents in cancer …

This review explores recent work directed toward the development of nanoparticles (NPs) for
multimodality cancer imaging and targeted cancer therapy. In the growing era of precision …

In recent decades, various classes of nanoparticles have been developed for optical
imaging of cancers. Many of these nanoparticles are designed to specifically target tumor …

Theranostic nanoparticles hold the potential to revolutionize disease management. Over the
last decade, there has been growing interest in the engineering of various kinds of …

Nanomedicine is the biomedical application of nanoscale materials for diagnosis and
therapy of disease. Recent advances in nanotechnology and biotechnology have …

Dual-modality imaging combines the complementary advantages of different modalities, and
offers the prospect of improved preclinical research. The combination of fluorescence …